Leadership Overview
Biomerics has 9 executives leading key functions including finance, human resources, manufacturing, and commercial operations.
Driven by innovation, Biomerics designs, develops, and produces advanced medical devices for diagnostic and interventional procedures, impacting global healthcare through comprehensive engineering and contract manufacturing services.
Driven by innovation, Biomerics designs, develops, and produces advanced medical devices for diagnostic and interventional procedures, impacting global healthcare through comprehensive engineering and contract manufacturing services.
Leadership Roles at Biomerics
Garrett Best - Chief Financial Officer
Garrett Best, the Chief Financial Officer at Biomerics, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and financial reporting, Best ensures robust financial health and sustainable growth. This leadership role involves managing capital allocation, optimizing investment strategies, and maintaining strong relationships with financial institutions. By analyzing market trends and economic indicators, Garrett Best drives financial performance and supports the company's expansion initiatives. The Chief Financial Officer's responsibilities extend to risk management and ensuring compliance with all financial regulations, safeguarding the company's assets and profitability.
Brett Poole - President, Manufacturing Capacity Expansion Continuous Improvement Revenue Growth
Brett Poole, the President, Manufacturing Capacity Expansion Continuous Improvement Revenue Growth at Biomerics, drives strategic initiatives focused on scaling production and enhancing operational output. Poole directs efforts to expand manufacturing capacity, implement lean methodologies for continuous improvement, and accelerate revenue growth. This multifaceted role involves optimizing production lines, identifying new market opportunities, and ensuring efficient resource utilization across all manufacturing facilities. By focusing on process optimization and strategic expansion, Brett Poole directly supports Biomerics' mission to deliver high-quality medical devices. The President's leadership ensures that manufacturing capabilities align with market demand and company growth objectives.

Chris Richardson - Chief Commercial Officer and President, International Division
Chris Richardson, the Chief Commercial Officer and President, International Division at Biomerics, spearheads global sales, marketing, and business development efforts. Richardson oversees the expansion of Biomerics' medical device solutions into international markets, driving commercial strategy and revenue generation. This leadership position involves cultivating strategic partnerships, managing global distribution channels, and ensuring market penetration. By focusing on customer needs and market dynamics, Chris Richardson directly enhances Biomerics' global presence and commercial success. The Chief Commercial Officer's responsibilities include developing go-to-market strategies and leading the international sales teams to achieve ambitious growth targets.

Freddy Delgado - President ASEPRECO
Freddy Delgado, the President ASEPRECO at Biomerics, leads the strategic direction and operational management of the ASEPRECO division. Delgado focuses on enhancing the division's capabilities in medical device development and manufacturing, ensuring alignment with Biomerics' overall mission. This role involves overseeing specific market segments and driving growth through targeted initiatives. By managing key operational aspects and fostering innovation within ASEPRECO, Freddy Delgado directly contributes to the company's specialized product offerings. The President's leadership ensures that ASEPRECO maintains high standards of quality and efficiency in its contributions to Biomerics' comprehensive service portfolio.
Art Seguin - President
Art Seguin, the President at Biomerics, directs overarching strategic initiatives and operational oversight for key business segments. Seguin focuses on driving growth, fostering innovation, and ensuring the successful execution of the company's mission in the medical device sector. This leadership role involves collaborating with other executives to define corporate objectives and implement effective business strategies. By guiding critical business functions and promoting operational excellence, Art Seguin directly supports Biomerics' commitment to developing and producing advanced diagnostic and interventional medical devices. The President's vision shapes the company's trajectory and market impact.

William Tarajos - Group President - Plastics
William Tarajos, the Group President - Plastics at Biomerics, leads the strategic development and operational execution for the company's plastics division. Tarajos oversees all aspects of plastic component design, engineering, and manufacturing for medical devices, ensuring adherence to stringent quality standards. This role involves driving innovation in polymer technologies and optimizing production processes to meet client demands. By focusing on advanced plastic solutions, William Tarajos directly enhances Biomerics' capabilities in producing critical medical device components. The Group President's leadership ensures the plastics division remains at the forefront of material science and manufacturing excellence.
Craig McCaffery - President
Craig McCaffery, the President at Biomerics, drives strategic growth and operational excellence across designated business units. McCaffery focuses on enhancing the company's capabilities in medical device design, development, and contract manufacturing. This leadership position involves fostering cross-functional collaboration and ensuring alignment with Biomerics' core mission. By championing innovation and optimizing resource allocation, Craig McCaffery directly contributes to the company's market leadership. The President's strategic oversight ensures that Biomerics consistently delivers high-quality solutions to the healthcare industry, supporting advancements in diagnostic and interventional procedures.
Brenda Medine - Chief of Staff
Brenda Medine, the Chief of Staff at Biomerics, enhances operational efficiency and strategic execution across the organization. Medine coordinates cross-functional initiatives, streamlines internal processes, and supports executive decision-making. This pivotal role involves managing key projects, facilitating communication between departments, and ensuring alignment with company objectives. By driving strategic priorities and optimizing resource allocation, Brenda Medine directly contributes to the company's operational excellence. The Chief of Staff's focus includes implementing best practices and fostering a culture of continuous improvement throughout Biomerics' medical device development and manufacturing operations.
Ben Harper - Chief Human Resources Officer
Ben Harper, the Chief Human Resources Officer at Biomerics, leads all human capital strategies and talent management initiatives. Harper oversees recruitment, employee development, compensation, and benefits programs, fostering a high-performance culture. This critical role ensures the organization attracts, retains, and develops top talent essential for designing and producing advanced medical devices. By championing employee engagement and cultivating a supportive work environment, Ben Harper directly impacts operational continuity and innovation. The Chief Human Resources Officer's strategic focus includes aligning HR policies with Biomerics' mission of delivering quality medical solutions and driving organizational growth.

Explore Leadership Teams in Manufacturing
Hologic is a global medical technology leader focused on improving womens health and wellbeing through early detection, diagnosis, and treatment solutions. The company develops and supplies advanced diagnostic products, imaging systems, and surgical tools that support clinical care across breast health, gynecological care and infectious disease testing. With a strong innovation culture and worldwide presence, Hologic partners with healthcare professionals to raise standards of care and help patients live healthier lives.
Company Leadership


Founded in 2001, Aeroflow Health is a pioneering healthcare company that leverages cutting-edge technology to support the delivery of medical products and services. With a steadfast commitment to empowering patients and improving their understanding of benefits, Aeroflow Health provides a curated experience for every individual and group. Offering a comprehensive portfolio of high-quality products, Aeroflow Health is dedicated to enhancing health outcomes and closing care gaps, ensuring that patients receive the care they deserve. Aeroflow's commitment to accessible healthcare has resulted in partnerships.
Company Leadership
CW
LB
AL
Peijia Medical is a global provider of innovative medical products and solutions, focusing on high-end medical devices in the fields of structural heart disease and neurovascular interventions. The company offers a comprehensive range of products including aortic, mitral, and tricuspid valves, as well as surgical accessories and neurovascular intervention products. With a commitment to continuous innovation, Peijia aims to provide safe, effective, and accessible solutions to improve patient quality of life. Their target clients include hospitals and healthcare providers dealing with cardiovascular and neurovascular diseases.
Company Leadership MZ
LT
JT
ESTABLISHMENT LABS HOLDINGS INC. (NASDAQ:ESTA) is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The Motiva Flora® tissue expander is the only regulatory-approved expander in the world with an integrated port that is MRI conditional and is used to improve outcomes in breast reconstruction following breast cancer. Mia Femtech, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 25 separate patent families worldwide and over 50 scientific studies and publications in peer-reviewed journals.
Company Leadership

CH
